HAP Trading, LLC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 231 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.38 and the average weighting 0.2%.

Quarter-by-quarter ownership
HAP Trading, LLC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$52,000
-34.2%
10,100
-53.0%
0.00%0.0%
Q1 2022$79,000
+75.6%
21,500
-29.5%
0.00%
+50.0%
Q4 2019$45,000
+28.6%
30,500
+39.9%
0.00%
-33.3%
Q3 2019$35,000
+52.2%
21,800
+15.3%
0.00%
+50.0%
Q2 2019$23,000
+53.3%
18,900
+57.5%
0.00%
+100.0%
Q1 2019$15,000
+650.0%
12,000
+12.1%
0.00%
Q4 2018$2,000
-87.5%
10,700
+7.0%
0.00%
-100.0%
Q2 2017$16,000
-97.0%
10,000
-86.2%
0.00%
-97.0%
Q1 2017$525,000
+262.1%
72,559
-26.4%
0.03%
+371.4%
Q4 2016$145,000
-47.5%
98,600
+10.0%
0.01%
-30.0%
Q3 2016$276,000
+153.2%
89,600
+16.8%
0.01%
+66.7%
Q2 2016$109,000
-90.6%
76,700
-87.7%
0.01%
-92.9%
Q1 2016$1,164,000
+7660.0%
623,400
+1794.8%
0.08%
+8400.0%
Q3 2015$15,000
-74.1%
32,900
-74.4%
0.00%
-50.0%
Q4 2014$58,000
-89.0%
128,600
-80.9%
0.00%
-90.5%
Q3 2014$529,000
-39.0%
673,400
+32.1%
0.02%
-34.4%
Q2 2014$867,000
+1634.0%
509,700
+718.1%
0.03%
+1500.0%
Q1 2014$50,000
-73.5%
62,300
-37.7%
0.00%
-66.7%
Q4 2013$189,000100,0000.01%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Third Security, LLC 19,305,403$233,209,00010.86%
BB BIOTECH AG 7,379,832$89,148,0003.13%
SENZAR ASSET MANAGEMENT, LLC 550,544$6,650,572,0001.72%
SNYDER CAPITAL MANAGEMENT L P 2,232,114$26,964,0001.69%
Sterling Global Strategies LLC 22,000$266,0000.98%
IRIDIAN ASSET MANAGEMENT LLC/CT 9,290,024$112,223,0000.98%
MSD Partners, L.P. 965,000$11,657,0000.94%
DOHENY ASSET MANAGEMENT /CA 130,950$1,582,0000.81%
Taylor Wealth Management Partners 128,110$1,548,0000.69%
Bellevue Group AG 318,000$3,841,0000.69%
View complete list of HALOZYME THERAPEUTICS INC shareholders